KIN
Income statement / Annual
Last year (2020), Kindred Biosciences, Inc.'s total revenue was $42.16 M,
an increase of 890.70% from the previous year.
In 2020, Kindred Biosciences, Inc.'s net income was -$23.62 M.
See Kindred Biosciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
| Period Ended |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
| Operating Revenue |
$42.16 M
|
$4.26 M
|
$1.97 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$4.63 M |
$587,000.00 |
$324,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$37.54 M |
$3.67 M |
$1.64 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0.89 |
0.86 |
0.84 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$31.28 M
|
$28.31 M
|
$26.40 M
|
$17.67 M
|
$13.86 M
|
$19.41 M
|
$18.69 M
|
$3.14 M
|
$75,000.00
|
| General & Administrative
Expenses |
$21.98 M
|
$37.93 M
|
$22.08 M
|
$11.90 M
|
$6.84 M
|
$6.86 M
|
$8.54 M
|
$1.08 M
|
$45,000.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$4.42 M
|
$2.08 M
|
$1.47 M
|
$992,000.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$21.98 M
|
$37.93 M
|
$26.50 M
|
$13.99 M
|
$8.31 M
|
$7.85 M
|
$8.54 M
|
$1.08 M
|
$45,000.00
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$53.26 M |
$66.24 M |
$52.90 M |
$31.65 M |
$22.17 M |
$27.26 M |
$27.23 M |
$4.22 M |
$120,000.00 |
| Cost And Expenses |
$57.89 M |
$66.82 M |
$53.22 M |
$31.65 M |
$22.17 M |
$27.26 M |
$27.23 M |
$4.22 M |
$120,000.00 |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$1.83 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$56.00 |
$0.00 |
| Depreciation &
Amortization |
$4.68 M
|
$2.54 M
|
$805,000.00
|
$475,000.00
|
$155,000.00
|
$146,000.00
|
$58,000.00
|
$3,129.00
|
$0.00
|
| EBITDA |
-$15.29 M
|
-$58.85 M
|
-$48.89 M
|
-$30.40 M
|
-$22.34 M
|
-$26.98 M
|
-$27.08 M
|
-$4.21 M
|
-$120,000.00
|
| EBITDA Ratio |
-0.36 |
-13.83 |
-24.87 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
-0.47
|
-14.42
|
-25.27
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$1.83 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$56.00
|
$0.00
|
| Income Before Tax |
-$21.80 M |
-$61.39 M |
-$49.69 M |
-$30.88 M |
-$22.50 M |
-$27.13 M |
-$27.14 M |
-$4.21 M |
-$120,000.00 |
| Income Before Tax Ratio
|
-0.52
|
-14.42
|
-25.27
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$1.83 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$56.00 |
$0.00 |
| Net Income |
-$23.62 M |
-$61.39 M |
-$49.69 M |
-$30.88 M |
-$22.50 M |
-$27.13 M |
-$27.14 M |
-$4.21 M |
-$120,000.00 |
| Net Income Ratio |
-0.56 |
-14.42 |
-25.27 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-0.6 |
-1.59 |
-1.6 |
-1.23 |
-1.13 |
-1.37 |
-1.44 |
-1.13 |
-0.0255 |
| EPS Diluted |
-0.6 |
-1.59 |
-1.6 |
-1.23 |
-1.13 |
-1.37 |
-1.44 |
-1.13 |
-0.0255 |
| Weighted Average Shares
Out |
$39.29 M
|
$38.66 M
|
$31.00 M
|
$25.08 M
|
$19.87 M
|
$19.77 M
|
$18.78 M
|
$3.73 M
|
$4.71 M
|
| Weighted Average Shares
Out Diluted |
$39.29 M
|
$38.66 M
|
$31.00 M
|
$25.08 M
|
$19.87 M
|
$19.77 M
|
$18.78 M
|
$3.73 M
|
$4.71 M
|
| Link |
|
|
|
|
|
|
|
|
|
